440 related articles for article (PubMed ID: 26412360)
1. Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.
Almeida H; Amaral MH; Lobao P; Frigerio C; Sousa Lobo JM
Curr Pharm Des; 2015; 21(36):5212-24. PubMed ID: 26412360
[TBL] [Abstract][Full Text] [Related]
2. Applications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: present and future considerations.
Almeida H; Amaral MH; Lobão P; Silva AC; Loboa JM
J Pharm Pharm Sci; 2014; 17(3):278-93. PubMed ID: 25224343
[TBL] [Abstract][Full Text] [Related]
3. Polymer-based carriers for ophthalmic drug delivery.
Imperiale JC; Acosta GB; Sosnik A
J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
[TBL] [Abstract][Full Text] [Related]
4. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
Mandal A; Bisht R; Rupenthal ID; Mitra AK
J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
[TBL] [Abstract][Full Text] [Related]
5. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
[TBL] [Abstract][Full Text] [Related]
6. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview.
Almeida H; Amaral MH; Lobão P; Sousa Lobo JM
Expert Opin Drug Deliv; 2013 Sep; 10(9):1223-37. PubMed ID: 23688342
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in ocular drug delivery.
Chen H
J Drug Target; 2015; 23(7-8):597-604. PubMed ID: 26453157
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
9. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D; Patra CN; Sahoo BM
Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
[TBL] [Abstract][Full Text] [Related]
10. Ocular application of chitosan.
Başaran E; Yazan Y
Expert Opin Drug Deliv; 2012 Jun; 9(6):701-12. PubMed ID: 22530690
[TBL] [Abstract][Full Text] [Related]
11. Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective.
Qamar Z; Qizilbash FF; Iqubal MK; Ali A; Narang JK; Ali J; Baboota S
Recent Pat Drug Deliv Formul; 2019; 13(4):246-254. PubMed ID: 31884933
[TBL] [Abstract][Full Text] [Related]
12. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
Fangueiro JF; Veiga F; Silva AM; Souto EB
Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
[TBL] [Abstract][Full Text] [Related]
13. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
[TBL] [Abstract][Full Text] [Related]
14. In vitro testing of thiolated poly(aspartic acid) from ophthalmic formulation aspects.
Budai-Szű Cs M; Horvát G; Gyarmati B; Szilágyi BÁ; Szilágyi A; Csihi T; Berkó S; Szabó-Révész P; Mori M; Sandri G; Bonferoni MC; Caramella C; Csányi E
Drug Dev Ind Pharm; 2016 Aug; 42(8):1241-6. PubMed ID: 26556306
[TBL] [Abstract][Full Text] [Related]
15. In Situ Gelling Ophthalmic Drug Delivery System: An Overview and Its Applications.
Sheshala R; Kok YY; Ng JM; Thakur RR; Dua K
Recent Pat Drug Deliv Formul; 2015; 9(3):237-48. PubMed ID: 26205681
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticles as drug/gene delivery systems to the retina.
del Pozo-Rodríguez A; Delgado D; Gascón AR; Solinís MÁ
J Ocul Pharmacol Ther; 2013 Mar; 29(2):173-88. PubMed ID: 23286300
[TBL] [Abstract][Full Text] [Related]
17. Newer approaches for optimal bioavailability of ocularly delivered drugs: review.
Kesavan K; Balasubramaniam J; Kant S; Singh PN; Pandit JK
Curr Drug Deliv; 2011 Mar; 8(2):172-93. PubMed ID: 21235476
[TBL] [Abstract][Full Text] [Related]
18. Emphasis on Nanostructured Lipid Carriers in the Ocular Delivery of Antibiotics.
Singh CP; Rai PK; Kumar M; Tiwari V; Tiwari A; Sharma A; Sharma K
Pharm Nanotechnol; 2024; 12(2):126-142. PubMed ID: 37519002
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.
Pignatello R; Carbone C; Puglia C; Offerta A; Bonina FP; Puglisi G
Ther Deliv; 2015; 6(11):1297-318. PubMed ID: 26608630
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles for ocular drug delivery.
Seyfoddin A; Shaw J; Al-Kassas R
Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
